In the published article, there were errors in Figures 5C, 6C. Due to Authors’ oversight during figure preparation, the ATF4 and β-actin image that was originally intended for Figure 2C was mistakenly placed again in Figure 5C. Additionally, in Figure 6C, the TUNEL and DAPI staining images for the siATF4 group were incorrectly inserted. The authors also replaced the ATF4 and β-actin images in Figure 6, as the originally selected images were not sufficiently representative of the observed trends. The corrected Figures 5, 6 and its caption appear below.
FIGURE 5
FIGURE 6
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
intestinal, ischemia reperfusion injury, paricalcitol, ATF4, CHOP, VDR (vitamin D receptor)
Citation
Zhang J, Liu T, Xue T and Jia Z (2025) Corrigendum: Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway. Front. Pharmacol. 16:1632205. doi: 10.3389/fphar.2025.1632205
Received
20 May 2025
Accepted
16 June 2025
Published
25 June 2025
Volume
16 - 2025
Edited and reviewed by
Daniele Maria-Ferreira, Instituto de Pesquisa Pelé Pequeno Príncipe, Brazil
Updates
Copyright
© 2025 Zhang, Liu, Xue and Jia.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tongqing Xue, vh6376@163.com; Zhongzhi Jia, jiazhongzhi.1998@163.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.